Hochschulschrift
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
- Weitere Titel
-
Allelverlust bei Patienten mit akuter myeloischer Leukämie und normalem Karyotyp
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Dresden, Technische Universität Dresden, Diss., 2009
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Dresden, Dresden
- (wer)
-
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, Technische Universität Dresden
- (wann)
-
2009
- Urheber
- Beteiligte Personen und Organisationen
-
Barth, Gerold
Jessberger, Rolf
- URN
-
urn:nbn:de:bsz:14-qucosa-25082
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Traikov, Sofia
- Barth, Gerold
- Jessberger, Rolf
- Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, Technische Universität Dresden
Entstanden
- 2009
Ähnliche Objekte (12)
Identification of CDX2 targets in acute myeloid leukaemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Characterisation of hypomethylating agent/IAP antagonist-induced cell death in acute myeloid leukaemia cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction
Single stem cell clones of an acute myeloid leukaemia patient display functional heterogeneity in vivo
Identification and characterization of a Y chromosome-encoded gene overexpressed in acute myeloid leukaemia cells
Identification of CDX2 targets in acute myeloid leukaemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Characterisation of hypomethylating agent/IAP antagonist-induced cell death in acute myeloid leukaemia cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction
Single stem cell clones of an acute myeloid leukaemia patient display functional heterogeneity in vivo
Identification and characterization of a Y chromosome-encoded gene overexpressed in acute myeloid leukaemia cells
Identification of CDX2 targets in acute myeloid leukaemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Characterisation of hypomethylating agent/IAP antagonist-induced cell death in acute myeloid leukaemia cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction
Single stem cell clones of an acute myeloid leukaemia patient display functional heterogeneity in vivo